1Haubner R, Wester HJ, Burkhart F, et al. Glycosylated RGD-containing peptides: tracer for tumor targeting and angiogenesis imaging with improved biokinetics[J]. J Nucl Med,2001,42(2): 326.
2Yu H, Raymonda JW, McMahon TM, et al. Detection of biological threat agents by immunomagnetic microsphere-based solid phase fluorogenic-and electro-chemiluminescence [ J ]. Biosens Bioelectron,2000,14 (10-11):829.
3Geary RS, Yu RZ, Watanabe T, et al. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl ) modified antisense oligonucleotide: comparison across species[ J ]. Drug Metab Dispos ,2003,31(11): 1419.
4罗建辉.关于生物制品活性的思考[J].药品技术审评论坛,2003,(3):782-782.
5Stute N, Furman WL, Schell M, et al. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration[ J]. J Pharm Sci, 1995, 84 (7) : 824.
6Sargent JM. The use of the MTT assay to study drug resistance in fresh tumour samples[ J ]. Recent Results Cancer Res ,2003,161:13.
7Lu ZY, Zhang XG, Gu ZJ, et al. A highly sensitive quantitative bioassay for human interleukin-11 [J]. J Immunol Methods, 1994,173(1):19.
8Ji QC, Rodila R, Gage EM, et al. A strategy of plasma protein quantitation by selective reaction monitoring of an intact protein[J].Anal Chem,2003,75(24) :7008.
9Chen X, Cushman SW, Pannell LK, et al. Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach [ J ]. J Proteome Res, 2005,4(2) :570.
